1. Miettinen, M. and J. Lasota, Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 2001. 438(1): p. 1-12.
2. Iorio, N., R.A. Sawaya, and F.K. Friedenberg, Review article: the biology, diagnosis and management of gastrointestinal stromal tumours. Aliment Pharmacol Ther, 2014. 39(12): p. 1376-86.
3. Miettinen, M., M. Sarlomo-Rikala, and J. Lasota, Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol, 1999. 30(10): p. 1213-20.
4. Pellino, G., et al., The experience of a referral centre and literature overview of GIST and carcinoid tumours in inflammatory bowel diseases. Int J Surg, 2015.
5. Dodd, L.G., et al., Fine-needle aspiration of gastrointestinal stromal tumors. Am J Clin Pathol, 1998. 109(4): p. 439-43.
6. Miettinen, M. and J. Lasota, Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol, 2006. 23(2): p. 70-83.
7. Miettinen, M., Z.F. Wang, and J. Lasota, DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol, 2009. 33(9): p. 1401-8.
8. van de Rijn, M., M.R. Hendrickson, and R.V. Rouse, CD34 expression by gastrointestinal tract stromal tumors. Hum Pathol, 1994. 25(8): p. 766-71.
9. Blay, J.Y., et al., Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol, 2005. 16(4): p. 566-78.
10. Ito, T., et al., Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature. Int J Clin Exp Pathol, 2014. 7(11): p. 8024-31.
11. DeMatteo, R.P., et al., Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg, 2000. 231(1): p. 51-8.
12. Blanke, C.D., et al., Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol, 2008. 26(4): p. 626-32.